These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 18675112

  • 1. The tailored medical therapy in patients with advanced heart failure referred for cardiac transplantation.
    Campana C, Alessandrino G, Striuli L, Agnesina L, Dequarti MC, Ghio S, Scelsi L, Tavazzi L.
    Transplant Proc; 2008; 40(6):1999-2000. PubMed ID: 18675112
    [Abstract] [Full Text] [Related]

  • 2. Early and medium term results of tailored therapy for heart failure.
    Martins S, Soares RM, do Rosário L, Quininha J, Antunes AM.
    Rev Port Cardiol; 2001 Mar; 20(3):261-82. PubMed ID: 11417309
    [Abstract] [Full Text] [Related]

  • 3. Reversal of end-stage heart failure is predicted by long-term therapeutic response rather than initial hemodynamic and neurohormonal profile.
    Levine TB, Levine AB, Goldberg D, Narins B, Goldstein S, Lesch M.
    J Heart Lung Transplant; 1996 Mar; 15(3):297-303. PubMed ID: 8777214
    [Abstract] [Full Text] [Related]

  • 4. Low-dose enoximone therapy in pre-transplant patients: hemodynamic, echocardiographic, and neurohumoral findings.
    Park JW, Heinzler R, Wirtz JH, Fieten-Rumswinkel M, Braun P, May E, Hetzer R, Heinrich KW.
    Z Kardiol; 1994 Mar; 83 Suppl 2():49-53. PubMed ID: 8091824
    [Abstract] [Full Text] [Related]

  • 5. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
    Campana C, Pasotti M, Klersy C, Alessandrino G, Albertini R, Magrini G, Ghio S, Tavazzi L.
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
    [Abstract] [Full Text] [Related]

  • 6. Prognostic stratification of women with chronic heart failure referred for heart transplantation: relevance of gender as compared with gender-related characteristics.
    Grigioni F, Barbieri A, Russo A, Reggianini L, Bonatti S, Potena L, Fabbri F, Coccolo F, Magnani G, Bursi F, Magelli C, Modena MG, Branzi A.
    J Heart Lung Transplant; 2006 Jun; 25(6):648-52. PubMed ID: 16730570
    [Abstract] [Full Text] [Related]

  • 7. Clinical and hemodynamic profile of patients with advanced heart failure considered for heart transplantation.
    Ortiz V, Martínez-Dolz L, Sánchez-Lacuesta E, Almenar L, Ten F, Andrés L, Moro J, Izquierdo MT, Agüero J, Salvador A.
    Transplant Proc; 2007 Sep; 39(7):2341-3. PubMed ID: 17889182
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tailored therapy before transplantation for treatment of advanced heart failure: effective use of vasodilators and diuretics.
    Stevenson LW.
    J Heart Lung Transplant; 1991 Sep; 10(3):468-76. PubMed ID: 1854776
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prognosis of patients removed from a transplant waiting list for medical improvement: implications for organ allocation and transplantation for status 2 patients.
    Hoercher KJ, Nowicki ER, Blackstone EH, Singh G, Alster JM, Gonzalez-Stawinski GV, Starling RC, Young JB, Smedira NG.
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1159-66. PubMed ID: 18455599
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT, Nikolaou M, Birmpa D, Farmakis D, Paraskevaidis I, Bistola V, Katsoulas T, Filippatos G, Kremastinos DT.
    Am J Cardiol; 2009 Jan 01; 103(1):73-5. PubMed ID: 19101233
    [Abstract] [Full Text] [Related]

  • 15. Proof of concept: hemodynamic response to long-term partial ventricular support with the synergy pocket micro-pump.
    Meyns B, Klotz S, Simon A, Droogne W, Rega F, Griffith B, Dowling R, Zucker MJ, Burkhoff D.
    J Am Coll Cardiol; 2009 Jun 30; 54(1):79-86. PubMed ID: 19555845
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A prognostic model for predicting waiting-list mortality for a total national cohort of adult heart-transplant candidates.
    Smits JM, Deng MC, Hummel M, De Meester J, Schoendube F, Scheld HH, Persijn GG, Laufer G, Van Houwelingen HC, Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group.
    Transplantation; 2003 Oct 27; 76(8):1185-9. PubMed ID: 14578751
    [Abstract] [Full Text] [Related]

  • 18. Prognostic factors and predictors of in-hospital mortality of patients with heart failure with preserved left ventricular ejection fraction.
    Pérez de Isla L, Zamorano J, Hernández N, Contreras L, Rodrigo JL, Almería C, Aubele AL, Mataix L, Macaya C.
    J Cardiovasc Med (Hagerstown); 2008 Oct 27; 9(10):1011-5. PubMed ID: 18799963
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.